RESTRUCTURING (Details) $ in Millions	12 Months Ended
	Dec. 31, 2023 USD ($) facility	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Feb. 16, 2024 CAD ($)	Feb. 16, 2024 USD ($)
Restructuring
Number of pharmaceutical manufacturing facilities | facility	3
Restructuring activity expense	$ 1,132,000	$ 5,679,000	$ 0
Assets held for sale	8,020,000	8,020,000
Disposal Group, Held-for-Sale, Not Discontinued Operations | Oakville, Ontario Former Manufacturing Facility | Subsequent Event
Restructuring
Consideration				$ 19.2	$ 14,200,000
Oakville, Ontario, Canada
Restructuring
Restructuring activity expense	1,100,000	5,700,000	$ 0
Restructuring accrual	100,000
Assets held for sale	8,000,000
Oakville, Ontario, Canada | Employee Severance
Restructuring
Restructuring activity expense	200,000	2,100,000
Oakville, Ontario, Canada | Facility Closing
Restructuring
Restructuring activity expense	700,000	3,100,000
Oakville, Ontario, Canada | Other Restructuring
Restructuring
Restructuring activity expense	$ 200,000	$ 400,000